ATE236644T1 - Dimeticon enthaltende aciclovirzusammensetzungen - Google Patents

Dimeticon enthaltende aciclovirzusammensetzungen

Info

Publication number
ATE236644T1
ATE236644T1 AT99965505T AT99965505T ATE236644T1 AT E236644 T1 ATE236644 T1 AT E236644T1 AT 99965505 T AT99965505 T AT 99965505T AT 99965505 T AT99965505 T AT 99965505T AT E236644 T1 ATE236644 T1 AT E236644T1
Authority
AT
Austria
Prior art keywords
dimeticon
aciclovir
compositions containing
compositions
containing dimeticon
Prior art date
Application number
AT99965505T
Other languages
English (en)
Inventor
Parbinder Cheema
David Gower
Andrew David Mounter
Timothy Giles Sabey
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10845017&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE236644(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE236644T1 publication Critical patent/ATE236644T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99965505T 1998-12-23 1999-12-21 Dimeticon enthaltende aciclovirzusammensetzungen ATE236644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9828620.6A GB9828620D0 (en) 1998-12-23 1998-12-23 Medicaments
PCT/EP1999/010155 WO2000038695A2 (en) 1998-12-23 1999-12-21 Aciclovir compositions containing dimethicone

Publications (1)

Publication Number Publication Date
ATE236644T1 true ATE236644T1 (de) 2003-04-15

Family

ID=10845017

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99965505T ATE236644T1 (de) 1998-12-23 1999-12-21 Dimeticon enthaltende aciclovirzusammensetzungen

Country Status (27)

Country Link
EP (1) EP1140117B1 (de)
JP (1) JP4145493B2 (de)
KR (1) KR100707329B1 (de)
CN (2) CN1191834C (de)
AR (1) AR021993A1 (de)
AT (1) ATE236644T1 (de)
AU (1) AU768989B2 (de)
BR (1) BR9916524A (de)
CA (1) CA2356895A1 (de)
CZ (1) CZ295770B6 (de)
DE (2) DE69906796T2 (de)
DK (1) DK1140117T3 (de)
ES (1) ES2196910T3 (de)
GB (2) GB9828620D0 (de)
HK (2) HK1039275A1 (de)
HU (1) HU230542B1 (de)
IL (2) IL143833A0 (de)
NO (1) NO322090B1 (de)
NZ (1) NZ512457A (de)
PE (1) PE20001351A1 (de)
PL (1) PL196629B1 (de)
PT (1) PT1140117E (de)
SI (1) SI1140117T1 (de)
TR (1) TR200102482T2 (de)
TW (1) TW585768B (de)
WO (1) WO2000038695A2 (de)
ZA (1) ZA200105071B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
CN102256602A (zh) * 2008-10-21 2011-11-23 诺沃德米克斯国际有限公司 用于治疗上皮组织的组合物
US20130324502A1 (en) * 2011-02-10 2013-12-05 Moberg Pharma Ab Novel formulations for dermal, transdermal and mucosal use 1
WO2015082172A1 (en) * 2013-12-03 2015-06-11 Zzip Ag Polydimethylsiloxane for the treatment of viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations
AU5381590A (en) * 1989-04-24 1990-10-25 Syntex (U.S.A.) Inc. Topical antiviral pharmaceutical composition containing a nonionic surfactant
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation
FR2728167A1 (fr) * 1994-12-15 1996-06-21 Cird Galderma Composition cosmetique ou dermatologique sous forme d'une emulsion eau dans huile a teneur elevee en hydroxyacides
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation

Also Published As

Publication number Publication date
WO2000038695A3 (en) 2000-10-26
IL143833A (en) 2006-12-31
AU2099700A (en) 2000-07-31
CZ20012332A3 (cs) 2001-12-12
NZ512457A (en) 2003-10-31
EP1140117A2 (de) 2001-10-10
CN1539421A (zh) 2004-10-27
SI1140117T1 (en) 2003-12-31
KR20010099932A (ko) 2001-11-09
DE69906796T2 (de) 2004-01-29
DE69906796D1 (de) 2003-05-15
HUP0104594A2 (en) 2002-06-29
CZ295770B6 (cs) 2005-11-16
HK1067548A1 (en) 2005-04-15
NO20013103L (no) 2001-08-20
JP2002542149A (ja) 2002-12-10
DK1140117T3 (da) 2003-07-21
TR200102482T2 (tr) 2003-03-21
PL349505A1 (en) 2002-07-29
BR9916524A (pt) 2001-10-02
CN100415237C (zh) 2008-09-03
GB0117795D0 (en) 2001-09-12
DE29924428U1 (de) 2003-08-28
AR021993A1 (es) 2002-09-04
EP1140117B1 (de) 2003-04-09
CN1191834C (zh) 2005-03-09
NO322090B1 (no) 2006-08-14
HUP0104594A3 (en) 2002-12-28
GB9828620D0 (en) 1999-02-17
WO2000038695A2 (en) 2000-07-06
HK1039275A1 (zh) 2002-04-19
PE20001351A1 (es) 2000-12-14
PT1140117E (pt) 2003-08-29
CA2356895A1 (en) 2000-07-06
TW585768B (en) 2004-05-01
JP4145493B2 (ja) 2008-09-03
GB2362105B (en) 2003-06-18
AU768989B2 (en) 2004-01-15
NO20013103D0 (no) 2001-06-21
KR100707329B1 (ko) 2007-04-13
ZA200105071B (en) 2002-09-20
HU230542B1 (hu) 2016-11-28
ES2196910T3 (es) 2003-12-16
IL143833A0 (en) 2002-04-21
CN1334737A (zh) 2002-02-06
GB2362105A (en) 2001-11-14
PL196629B1 (pl) 2008-01-31

Similar Documents

Publication Publication Date Title
ID26549A (id) Komposisi-komposisi epotilon
ATE367793T1 (de) Schweisshemmende zusammensetzungen
DE69832516D1 (de) Isoflavon-enthaltende zusammensetzungen
DE69836106D1 (de) Stanolester enthaltende Zusammensetzungen
NO20005215L (no) Dihydropyrimidiner
IS5046A (is) Lyfjasamsetningar
DE69900634T2 (de) Shampoozusammensetzungen
DE69919953D1 (de) Funktionelle zusammensetzungen
ATE469550T1 (de) Antiparasitäre zusammensetzungen
DE69929799D1 (de) Ultraviolettlicht absorbierende zusammensetzungen
DE69927758D1 (de) Imidosilan-Zusammensetzungen
DE69838290D1 (de) Vernetzungszusammensetzungen
DE69942892D1 (de) Gaserzeugende zusammensetzung
DE69928862D1 (de) Zusammensetzung
ID27889A (id) Komposisi-komposisi kopolimer polisiklik
DE69837482D1 (de) Entschäumende zusammensetzungen
DE69935609D1 (de) Formulierungen enthaltend cefuroxim-axetil
DE69809175T2 (de) Flavanon-enthaltende Zusammensetzungen
ID25650A (id) Komposisi-komposisi sampo
DE69826706D1 (de) Wäscheweichmittelzusammensetzungen
DE59911376D1 (de) Resektionsinstrument
IS5569A (is) Lyfjasamsetningar
ATE236644T1 (de) Dimeticon enthaltende aciclovirzusammensetzungen
DE59911336D1 (de) Riechstoff-zusammensetzungen
ID30224A (id) Komposi-komposisi fungisida

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140117

Country of ref document: EP